Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RhDNase Effect on Biodistribution of PMN Serine Proteases in Cystic Fibrosis Sputum
NCT00843817Phase 4Completed
- Sponsor
- University Hospital Tours
- Start
- Apr 2009
- Primary completion
- Apr 2013
- Modality
- Replacement Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of dornase alfa in cystic fibrosis (CF), sponsored by University Hospital Tours. Primary endpoint: Biodistribution of elastase, Protease 3 and cathepsine G in the expectorations at 1 hour. Started Apr 2009; status: completed.
02
Drugs
dornase alfa
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on NCT00843817.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00843817.